Related Experiment Video
Updated: Oct 22, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Redox Signaling and Sarcopenia: Searching for the Primary Suspect
Nicholas A Foreman1, Anton S Hesse1, Li Li Ji1
1Laboratory of Physiological Hygiene and Exercise Science, School of Kinesiology, College of Education and Human Development, University of Minnesota, 1900 University Ave, Minneapolis, MN 55455, USA.
Abstract:
Sarcopenia, the age-related decline in muscle mass and function, derives from multiple etiological mechanisms. Accumulative research suggests that reactive oxygen species (ROS) generation plays a critical role in the development of this pathophysiological disorder. In this communication, we review the various signaling pathways that control muscle metabolic and functional integrity such as protein turnover, cell death and regeneration, inflammation, organismic damage, and metabolic functions. Although no single pathway can be identified as the most crucial factor that causes sarcopenia, age-associated dysregulation of redox signaling appears to underlie many deteriorations at physiological, subcellular, and molecular levels. Furthermore, discord of mitochondrial homeostasis with aging affects most observed problems and requires our attention. The search for the primary suspect of the fundamental mechanism for sarcopenia will likely take more intense research for the secret of this health hazard to the elderly to be unlocked.
More Related Videos
Related Concept Videos
Redox Reactions
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response

